News Mednow Announces the Graduation to OTCQX Trading, to expand Access to U.S. Investors May 9, 2022 | Press Release Mednow Provides Revenue Guidance on Fiscal Q3 2022, a Projected Record C$5 – C$5.5 Million in Quarterly Revenue, Q/Q Growth of Approx. 175% Apr 26, 2022 | Press Release Mednow.ca Launches a Licenced Pharmacy in Manitoba; Designed to Improve Health Outcomes Through Unlimited Pharmacist Consults, and More Apr 18, 2022 | Press Release Mednow Closes Previously Announced Acquisition of Pharmacy in Toronto Apr 1, 2022 | Press Release Mednow to Attend DC Finance’s Montreal Conference on April 5th, 2022 Mar 30, 2022 | Press Release Mednow to Attend Lytham Partners Spring 2022 Investor Conference Mar 28, 2022 | Press Release Mednow Achieves Record Q2 2022 Financial Results with 230% Q/Q Revenue Growth and 1,400% Y/Y Revenue Growth Mar 23, 2022 | Press Release Mednow to Attend 8th Annual AlphaNorth Capital Conference Mar 22, 2022 | Press Release Mednow Launches Personalized Supplement Program Mar 16, 2022 | Press Release Mednow to Host Q2/22 Conference Call on Wednesday March 23, 2022, at 8:30am EST on Financial Results and Corporate Update Mar 15, 2022 | Press Release « Older Entries
Mednow Announces the Graduation to OTCQX Trading, to expand Access to U.S. Investors May 9, 2022 | Press Release
Mednow Provides Revenue Guidance on Fiscal Q3 2022, a Projected Record C$5 – C$5.5 Million in Quarterly Revenue, Q/Q Growth of Approx. 175% Apr 26, 2022 | Press Release
Mednow.ca Launches a Licenced Pharmacy in Manitoba; Designed to Improve Health Outcomes Through Unlimited Pharmacist Consults, and More Apr 18, 2022 | Press Release
Mednow Achieves Record Q2 2022 Financial Results with 230% Q/Q Revenue Growth and 1,400% Y/Y Revenue Growth Mar 23, 2022 | Press Release
Mednow to Host Q2/22 Conference Call on Wednesday March 23, 2022, at 8:30am EST on Financial Results and Corporate Update Mar 15, 2022 | Press Release
